Which has grown faster, GMED or TXG?

Over the past five years, GMED grew revenue faster — GMED at a 27.65% CAGR versus TXG at 8.74%.

Is GMED or TXG more profitable?

GMED runs the higher net margin — GMED at 17.03% versus TXG at -12.18%.

How have GMED and TXG total returns compared?

Over the past 5 years, GMED delivered -0.33% and TXG delivered -7.24% annualized total return. Past performance doesn't predict future results.

Globus Medical, Inc. (GMED) vs 10x Genomics, Inc. (TXG)

A side-by-side comparison of Globus Medical, Inc. and 10x Genomics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

GMED

Globus Medical, Inc.

$10.31B

$76.43HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

TXG

10x Genomics, Inc.

$10.24B

$80.66HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — GMED vs TXG

growth of $100 · dividends reinvested · last 7y

GMED +54.2% (+6.4%/yr)TXG +85.3% (+9.2%/yr)TXG compounded faster over this window

GMED TXG

GMED vs TXG: by the numbers

•GMED is the larger company ($10.31B vs $10.24B market cap).
•GMED is profitable (17.03% net margin) while TXG runs a net loss (-12.18%).
•GMED grew revenue faster over the past five years (27.65% vs 8.74% CAGR).

Metrics side by side

Valuation

Metric	GMED	TXG
P/E ratio	19.65	N/A
Forward P/E	15.28	N/A
PEG ratio	0.63	N/A
P/S ratio	3.28	16.60
P/B ratio	2.16	12.40
EV / EBITDA	10.62	N/A
FCF yield	7.28%	1.19%

Profitability

Metric	GMED	TXG
Gross margin	68.55%	70.03%
Operating margin	20.75%	-14.33%
Net margin	17.03%	-12.18%
ROE	11.23%	-9.10%
ROIC	10.49%	-9.57%

Growth (annualized)

Metric	GMED	TXG
Revenue CAGR (5Y)	27.65%	8.74%
EPS CAGR (5Y)	30.79%	N/A
FCF CAGR (5Y)	29.93%	N/A
Total return CAGR (5Y)	-0.33%	-7.24%

Frequently asked

Which has grown faster, GMED or TXG?: Over the past five years, GMED grew revenue faster — GMED at a 27.65% CAGR versus TXG at 8.74%.
Is GMED or TXG more profitable?: GMED runs the higher net margin — GMED at 17.03% versus TXG at -12.18%.
How have GMED and TXG total returns compared?: Over the past 5 years, GMED delivered -0.33% and TXG delivered -7.24% annualized total return. Past performance doesn't predict future results.

Go deeper

Full GMED analysis Full TXG analysis Interactive comparison tool

Dig into the metrics

Globus Medical P/E ratio Globus Medical ROE 10x Genomics ROE Globus Medical operating margin 10x Genomics operating margin Globus Medical revenue growth 10x Genomics revenue growth Globus Medical free cash flow 10x Genomics free cash flow

Globus Medical & 10x Genomics appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.